New York Life Investment Management LLC Iovance Biotherapeutics, Inc. Transaction History

New York Life Investment Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 05, 2024	SELL	$3.3 - $8.89 $4,336 - $11,681	-1,314 Reduced 2.25%	56,959 $463,000
Q3 2023 Nov 07, 2023	SELL	$4.44 - $8.79 $40,754 - $80,683	-9,179 Reduced 13.61%	58,273 $265,000
Q2 2023 Aug 04, 2023	SELL	$5.36 - $9.06 $20,378 - $34,446	-3,802 Reduced 5.34%	67,452 $474,000
Q1 2023 May 08, 2023	BUY	$5.53 - $8.22 $394,034 - $585,707	71,254 New	71,254 $435,000

314

241M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.38B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of New York Life Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on New York Life Investment Management LLC with notifications on news.